Document is current

Article History

Received: 3 November 2023

Accepted: 20 July 2024

First Online: 2 August 2024

Declarations

:

: This project has been approved by the Ethics Committee of the Technical University of Munich on May 5, 2023 (2023–190-S-SR).

: Not applicable.

: Spyridon Siafis, none reported. Hui Wu, none reported. Nobuyuki Nomura has received speaker fees from Eisai, Meiji Seika Pharma, Otsuka, and Sumitomo Pharma and manuscript fees from Sumitomo Pharma. Johannes Schneider-Thoma, none reported. Irene Bighelli, none reported. Carolin Lorenz, none reported. Joseph E. Dib is author of potentially eligible trials and no other conflicts of interest reported. Prathap Tharyan is author of potentially eligible trials and no other conflicts of interest reported. Leonie A. Calver is author of potentially eligible trials and no other conflicts of interest reported. Geoffrey K. Isbister is author of potentially eligible trials and no other conflicts of interest reported. Esther W. Y. Chan reports grants from the Hong Kong Research Grants Council of the Government of the Hong Kong SAR, Research Fund Secretariat of the Food and Health Bureau, National Natural Science Fund of China, Wellcome Trust, Bayer, Bristol-Myers Squibb, Pfizer, Janssen, Amgen, Takeda, RGA Reinsurance Company, AstraZeneca, Narcotics Division of the Security Bureau of the Hong Kong Special Administrative Region, Innovation and Technology Commission of the Government of the Hong Kong Special Administrative Region, Novartis, and National Health and Medical Research Council Australia and honorarium from Hospital Authority, outside the submitted work. E. W. Y. C. is also author of potentially eligible trials. Jonathan C. Knott is author of potentially eligible trials and no other conflicts of interest reported. Celene Y. L. Yap is author of potentially eligible trials and no other conflicts of interest reported. Célia Mantovani is author of potentially eligible trials and no other conflicts of interest reported. Marc L. Martel is author of potentially eligible trials and no other conflicts of interest. David Barbic is author of potentially eligible trials and no other conflicts of interest reported. William G. Honer has served as a consultant to Translational Life Sciences, Newron, AbbVie, and Boehringer Ingelheim. W. G. H. is also author of potentially eligible trials reported. Wulf-Peter Hansen, none reported. Gisele Huf is author of potentially eligible trials and no other conflicts of interest reported. Jacob Alexander is author of potentially eligible trials and no other conflicts of interest reported. Nirmal S. Raveendran is author of potentially eligible trials and no other conflicts of interest reported. Evandro S. F. Coutinho is author of potentially eligible trials and no other conflicts of interest reported. Josef Priller, none reported. Clive E. Adams is author of potentially eligible trials and no other conflicts of interest reported. Georgia Salanti, none reported. Stefan Leucht has in the last 3 years received honoraria for advising/consulting and/or for lectures and/or for educational material from Angelini, Boehringer Ingelheim, Eisai, Ekademia, Gedeon Richter, Janssen, Karuna, Kynexis, Lundbeck, Medichem, Medscape, Mitsubishi, Otsuka, Novo Nordisk, Recordati, Rovi, and Teva.